Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Immunology Market by, Drug Class
6.1 Overview
6.2 Fusion Proteins
6.3 Immunosuppressants
6.4 Monoclonal Antibody (mAb)
6.5 Polyclonal Antibody (pAb)
6.6 Other Drug Classes


7 Global Immunology Market by, Disease Indication
7.1 Overview
7.2 Ankylosing Spondylitis
7.3 Inflammatory Bowel Disease
7.4 Plaque Psoriasis
7.5 Prophylaxis of Organ Rejection
7.6 Psoriatic Arthritis
7.7 Rheumatoid Arthritis
7.8 Other Disease Indications


8 Global Immunology Market by, Distribution Channel
8.1 Overview
8.2 Hospital Pharmacies
8.3 Online Pharmacies
8.4 Retail Pharmacies
8.5 Other Distribution Channels


9 Global Immunology Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa


10 Key Developments


11 Company Profiling
11.1 Abbvie Inc.
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 ALLERGAN
11.3 Amgen Inc.
11.4 Astellas
11.5 AstraZeneca
11.6 Bristol-Myers Squibb Company
11.7 Eli Lilly and Company
11.8 F. Hoffmann-La Roche Ltd
11.9 Janssen Global Service,LLC (Johnson and Johnson)
11.10 Merck Sharp and Dohme Corp.
11.11 Novartis AG
11.12 Pfizer Inc.
11.13 UCB SA